Skip to content
value.today

Sequent Scientific Limited

SEQUENT.BO
$1.1 Bmarket cap on Nov 19, 2026+191.5% since Jan 2024
1D
+0.2%
Compare
World rank
#8,815
Revenue
$177 M
Mar-2022 ending year
value.today research
Net income
$5 M
2.8% margin
value.today research
Employees
—

Sequent Scientific Limited in brief

Sequent Scientific Limited is a listed company in the Pharmaceutical industry, based in India. Its market value was $1.1 B on 19 November 2026, which makes it the 8,815th largest listed company in the world and the 588th largest in India on this site. In the year to Mar 2022 it had sales of $177 M and a net profit of $5 M, about 3 cents of profit for every dollar of sales. Its shares trade under the symbol SEQUENT.BO (BSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Sequent Scientific Limited timeline

1 events, 2016
  1. 2016
  2. 📈
    Listed on National Stock Exchange of India as VIYASH
    First day of listing in the exchange's official list.

Events of Sequent Scientific Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Sequent Scientific Limited share price · NSE (VIYASH.NS)

daily · 202 trading days since 2026
Last close 235.84 INR (Nov 19, 2026)1 month: +6.7%52-week range 178.13 – 298.00 INR
$0 M$79 M$159 M$238 M$318 M
DateOpenHighLowCloseChangeVolume
Nov 19, 2026236.55238.90235.10235.84+0.1%1.0 M
Nov 18, 2026235.80237.11228.81235.61-0.8%2.2 M
Nov 17, 2026236.38241.64235.05237.40+0.4%2.1 M
Nov 16, 2026244.00249.40232.50236.38-7.4%8.3 M
Nov 13, 2026253.00259.00247.50255.32+1.2%3.2 M
Nov 12, 2026255.91258.50248.01252.23-0.9%3.6 M
Nov 11, 2026241.00257.00239.00254.64+7.2%5.1 M
Nov 9, 2026236.10241.87234.67237.51+3.5%2.4 M
Nov 6, 2026231.20232.40225.70229.48-1.4%1.0 M
Nov 5, 2026232.00234.40228.51232.82+1.9%2.2 M
Nov 4, 2026217.50229.58215.00228.46+4.1%1.6 M
Nov 3, 2026222.48222.99218.20219.45-0.4%847,696
Nov 2, 2026218.39221.87216.29220.31+0.9%862,955
Oct 30, 2026224.59225.84217.35218.39-2.7%1.1 M
Oct 29, 2026228.90233.00222.11224.55-1.1%2.6 M
Oct 28, 2026215.00230.99212.50227.00+5.6%4.6 M
Oct 27, 2026207.00217.90206.48214.87+3.4%1.5 M
Oct 26, 2026202.41212.60202.19207.87+1.8%3.3 M
Oct 23, 2026208.30208.50197.10204.18-1.8%4.5 M
Oct 22, 2026213.10215.59207.30207.99-2.6%2.1 M
Oct 21, 2026222.39222.88204.15213.58-3.4%3.5 M
Oct 19, 2026229.19229.19218.41221.11-2.2%3.0 M
Oct 16, 2026226.00229.00220.62226.00+0.0%2.2 M
Oct 15, 2026233.28233.61224.25225.93-3.0%1.2 M
Oct 14, 2026235.80235.80231.95232.98-0.9%1.2 M
Oct 13, 2026236.60237.20232.20235.02-0.4%1.0 M
Oct 12, 2026236.45241.90234.50235.88+0.8%1.4 M
Oct 9, 2026236.01239.76232.29234.06-0.8%1.6 M
Oct 8, 2026241.90250.90235.01235.86-2.0%3.8 M
Oct 7, 2026234.00242.67232.16240.77—3.1 M

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Sequent Scientific Limited share price statistics

computed nightly from the daily prices
NSE · VIYASH.NSClose 235.84 INR (Nov 19, 2026)
1 day
+0.1%
1 week
-6.5%
1 month
+6.7%
3 months
-13.1%
Year to date
—
1 year
—
3 years
—
5 years
—
10 years
—
52-week low 178.13-20.9% from the highhigh 298.00
Highest on record 298.00 INR (Jul 6, 2026)Volume 2.5 M shares/dayValue traded 587.3 M INR/dayVolatility 47% (30d), 43% (1y)202 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$323 M$646 M$969 M$1.3 B2020202120222023202420252026

World rank over time

▲ up 5,953 places since 2020
2020-01-01: #14769#14,76920202021-01-01: #10489#10,48920212022-01-07: #12832#12,83220222022-12-25: #16681#16,68120222023-07-30: #16471#16,47120232024-01-05: #14249#14,24920242026-11-12: #8606#8,60620262026-11-13: #8544#8,54420262026-11-16: #8853#8,85320262026-11-17: #8808#8,80820262026-11-18: #8841#8,84120262026-11-19: #8816#8,8162026

Rank in India: #519 (Jan 2020) · #403 (Jan 2021) · #573 (Jan 2022) · #735 (Dec 2022) · #802 (Jul 2023) · #763 (Jan 2024) · #574 (Nov 2026) · #572 (Nov 2026) · #587 (Nov 2026) · #587 (Nov 2026) · #588 (Nov 2026) · #588 (Nov 2026)

Key ratios

market cap and latest results
P/E ratio
223.3×
Price / sales
6.3×
Price / book
12.0×
Free cash flow yield
—
Net margin
2.8%
Operating margin
—
Return on equity
5.4%
Liabilities / assets
48.9%

Annual results

Revenue
$177 M
Operating income
—
Net income
$5 M

Mar-2022 ending year

Balance sheet

Total assets
$180 M
Total liabilities
$88 M
Total equity
$93 M

Mar-2022 ending year

Mutual funds holding Sequent Scientific Limited#

6 funds in 2 countries hold shares worth $6 M. Since their previous reports 1 added shares and 2 sold, selling $0 M net. By country: USA 5 ($5 M), India 1 ($1 M).
Mutual funds holding Sequent Scientific Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc.1.60 M$5 M—0.03%no changeJun 30, 2026
🇮🇳 Motilal Oswal Nifty Microcap 250 Index FundMotilal Oswal Asset Management419,474$1 M—0.42%−1.9%Oct 31, 2026
🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc.88,695$0 M—0.04%−3.3%Jun 30, 2026
🇺🇸 State Street SPDR S&P Emerging Asia Pacific ETFSSGA Funds Management, Inc.77,414$0 M—0.05%+7.7%Jun 30, 2026
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust4,729$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust193$0 M—<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 6 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where Sequent Scientific Limited operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Sequent Scientific Limited: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Sequent Scientific Limited: countries of operation
CountryPresenceRevenue there
🇮🇳 IndiaHeadquarters—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Discuss Sequent Scientific Limited#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 6 funds hold $6 millionautomatic update · Oct 31, 2026

    6 mutual funds in 2 countries hold shares of Sequent Scientific Limited worth $6 million (funds' newest reports, up to 31 October 2026). Since their previous reports 1 funds added shares and 2 sold; on balance they sold $10,000. Share splits are not counted as trading.

How Sequent Scientific Limited compares in Pharmaceutical

  • Market cap$1.1 B · higher than 55% of 393
  • Revenue$177 M · higher than 28% of 324
  • Net margin2.8% · higher than 32% of 313
  • P/E ratio223.3× · lower than 3% of 172
  • Price / sales6.3× · lower than 21% of 219
  • Price / book12.0× · lower than 6% of 207

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Sequent Scientific Limited🇮🇳$1.1 B223.3×2.8%—
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Nov 19, 2026
Annual results:
Mar-2022 ending year
Balance sheet:
Mar-2022 ending year
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Sequent Scientific Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Sequent Scientific Limited's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Sequent Scientific Limited? Suggest a correction